EUVIMEDEUVIMED entdecken
Open Access

Target‐Guided Design and Synthesis of Aryl‐Functionalized Promysalin Analogs

Martina M Golden, Carter U Brzezinski, William M Wuest iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202401030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Martina M Golden und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Emory University, Atlanta, GA, 30322, USA. Hauptthemen laut MEDLINE: Salicylamides, Pyrrolidines, Pseudomonas aeruginosa, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of new narrow‐spectrum antibiotics is a promising approach to combat antibiotic resistance. Promysalin, a secondary metabolite isolated from Pseudomonas putida , exhibits potent species‐specific inhibition of the pathogen P. aeruginosa (IC 50 21 nM). Herein, the total synthesis and stereochemical assignment of promysalin, structure–activity relationship studies, and the identification of its molecular target, succinate dehydrogenase, are previously reported by the group. These findings enable computational studies of promysalin's interactions with succinate dehydrogenase, revealing a novel binding site region primed for π–π stacking interactions with a nearby tryptophan residue. It is hypothesized that new aromatic analogs of promysalin can target this beneficial interaction, potentially leading to more potent inhibitors of P. aeruginosa growth. Herein, the in silico design of these analogs, a scalable and general synthetic route to access them, and characterization of their activity against a panel of clinically relevant P. aeruginosa strains are reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SalicylamidesPyrrolidinesPseudomonas aeruginosaAnti-Bacterial AgentsMolecular Docking SimulationSuccinate DehydrogenaseEnzyme Inhibitors

Stichwörter der Autor:innen

Pseudomonas aeruginosaantibacterialsdivergent synthesesmolecular dockingspromysalins

Substanzen

promysalinSalicylamidesPyrrolidinesAnti-Bacterial AgentsSuccinate DehydrogenaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, Emory University, Atlanta, GA, 30322, USA.
  • Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA, 30322, USA.

ORCID-Profile: William M Wuest

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Golden, M. M., Brzezinski, C. U., & Wuest, W. M. (2025). Target‐Guided Design and Synthesis of Aryl‐Functionalized Promysalin Analogs. ChemBioChem. https://doi.org/10.1002/cbic.202401030

Vancouver

Golden MM, Brzezinski CU, Wuest WM. Target‐Guided Design and Synthesis of Aryl‐Functionalized Promysalin Analogs. ChemBioChem. 2025. doi:10.1002/cbic.202401030

BibTeX
@article{Golden2025,
  author = {Golden, Martina M and Brzezinski, Carter U and Wuest, William M},
  title = {Target‐Guided Design and Synthesis of Aryl‐Functionalized Promysalin Analogs},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202401030}
}
Kostenlos starten →